Sriveda Boyalakuntla/LinkedIn
Jan 4, 2026, 21:39
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn:
”Grateful for the opportunity to attend ASH25 and present our work on abbreviated DOAC therapy for pediatric infection-associated cerebral venous sinus thrombosis.
I’m honored to have received an Abstract Achievement Award for this work.
A huge thank you to Dr. Riten Kumar for the incredible mentorship and guidance throughout this project without whose support this experience would not be possible.
I learned so much from the conference, listening to experts in hematology, meeting inspiring professionals, and engaging with the hematology community.
I’m excited to carry these insights forward in my future endeavors.”
Stay updated with Hemostasis Today.
-
Feb 20, 2026, 10:26Eithne Sexton: Our Interactive Dashboards for Future Stroke Projections at SPHeRE Conference
-
Feb 20, 2026, 10:06Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation
-
Feb 20, 2026, 09:50Latifa Alhassan: HIV Is a Danger Looming For Our Unborn Children and For The Economy of Ghana
-
Feb 20, 2026, 09:35Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
-
Feb 20, 2026, 09:27Waseem Mujahed: Compartment Syndrome as the Initial Presentation of Postpartum Acquired Hemophilia
-
Feb 20, 2026, 09:21Piotr Czempik: Viscoelastic Testing Guiding Lumbar Puncture in Waldenström’s Macroglobulinemia
-
Feb 20, 2026, 09:14Edoxaban Versus Dalteparin in Cancer-Associated VTE – JTH
-
Feb 20, 2026, 09:04Rens De Groot: The 1st Reported Case of Caplacizumab Resistance
-
Feb 20, 2026, 08:58Adeniji Mustapha: Advocacy for Health Doesn’t Require a License